CHRONIC IDIOPATHIC URTICARIA
Clinical trials for CHRONIC IDIOPATHIC URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC IDIOPATHIC URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC IDIOPATHIC URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could tame stubborn hives when antihistamines fail
Disease control CompletedThis phase 2 trial tested an oral drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives and itching lasting months) that standard antihistamines couldn't control. Participants took either povorcitinib or a placebo for 12 weeks to see if the drug reduced…
Matched conditions: CHRONIC IDIOPATHIC URTICARIA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New biosimilar aims to tame stubborn hives at lower cost
Disease control CompletedThis completed Phase 3 trial tested whether TEV-45779, a biosimilar of the drug omalizumab (XOLAIR), works as well as the original for people with chronic hives that don't improve with antihistamines. 608 participants received either the biosimilar or XOLAIR. The main goal was to…
Matched conditions: CHRONIC IDIOPATHIC URTICARIA
Phase: PHASE3 • Sponsor: Teva Pharmaceuticals USA • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC